JP2014517069A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014517069A5 JP2014517069A5 JP2014517112A JP2014517112A JP2014517069A5 JP 2014517069 A5 JP2014517069 A5 JP 2014517069A5 JP 2014517112 A JP2014517112 A JP 2014517112A JP 2014517112 A JP2014517112 A JP 2014517112A JP 2014517069 A5 JP2014517069 A5 JP 2014517069A5
- Authority
- JP
- Japan
- Prior art keywords
- difluoro
- tetrazol
- difluorophenyl
- propan
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 23
- 125000000217 alkyl group Chemical group 0.000 claims description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 17
- 125000005843 halogen group Chemical group 0.000 claims description 13
- 201000010099 disease Diseases 0.000 claims description 10
- 125000001072 heteroaryl group Chemical group 0.000 claims description 10
- 125000003118 aryl group Chemical group 0.000 claims description 8
- 125000001188 haloalkyl group Chemical group 0.000 claims description 6
- -1 2-quinolinyl Chemical group 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 4
- 125000004438 haloalkoxy group Chemical group 0.000 claims description 4
- 125000004001 thioalkyl group Chemical group 0.000 claims description 4
- 125000003342 alkenyl group Chemical group 0.000 claims description 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 3
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical group C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
- 125000002877 alkyl aryl group Chemical group 0.000 claims description 2
- 125000000304 alkynyl group Chemical group 0.000 claims description 2
- 125000005018 aryl alkenyl group Chemical group 0.000 claims description 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 2
- 125000005015 aryl alkynyl group Chemical group 0.000 claims description 2
- 125000000232 haloalkynyl group Chemical group 0.000 claims description 2
- 125000005347 halocycloalkyl group Chemical group 0.000 claims description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 125000003107 substituted aryl group Chemical group 0.000 claims description 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 8
- 208000035475 disorder Diseases 0.000 claims 7
- 239000003814 drug Substances 0.000 claims 7
- 229940079593 drug Drugs 0.000 claims 5
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 claims 4
- 210000003169 central nervous system Anatomy 0.000 claims 4
- 230000001404 mediated effect Effects 0.000 claims 4
- BSWSAXNDRRRWHT-UHFFFAOYSA-N 1-(1,3-benzothiazol-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1SC2=CC=CC=C2N=1)(O)CN1C=NN=N1 BSWSAXNDRRRWHT-UHFFFAOYSA-N 0.000 claims 3
- GPLQUAMQMYCLMQ-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-1-quinolin-2-yl-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=C2C=CC=CC2=CC=1)(O)CN1C=NN=N1 GPLQUAMQMYCLMQ-UHFFFAOYSA-N 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- ZAHUSXVPZMFMSF-UHFFFAOYSA-N 1,1-difluoro-2-(4-fluorophenyl)-3-(tetrazol-1-yl)-1-[5-[4-(trifluoromethoxy)phenyl]pyrazin-2-yl]propan-2-ol Chemical compound C=1C=C(F)C=CC=1C(C(F)(F)C=1N=CC(=NC=1)C=1C=CC(OC(F)(F)F)=CC=1)(O)CN1C=NN=N1 ZAHUSXVPZMFMSF-UHFFFAOYSA-N 0.000 claims 2
- PQZSGYYELIGLCJ-UHFFFAOYSA-N 1-(5-bromothiophen-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1SC(Br)=CC=1)(O)CN1C=NN=N1 PQZSGYYELIGLCJ-UHFFFAOYSA-N 0.000 claims 2
- QXDLOJRAQLRLBT-UHFFFAOYSA-N 1-(5-chloropyrazin-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=CC(Cl)=NC=1)(O)CN1C=NN=N1 QXDLOJRAQLRLBT-UHFFFAOYSA-N 0.000 claims 2
- GWVCFCRFDMCWAG-UHFFFAOYSA-N 1-(6-bromoquinolin-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=C2C=CC(Br)=CC2=CC=1)(O)CN1C=NN=N1 GWVCFCRFDMCWAG-UHFFFAOYSA-N 0.000 claims 2
- CGQRRXIQHKQABV-UHFFFAOYSA-N 1-(6-bromoquinoxalin-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=C2C=CC(Br)=CC2=NC=1)(O)CN1C=NN=N1 CGQRRXIQHKQABV-UHFFFAOYSA-N 0.000 claims 2
- DISWUHUIHBBZPN-UHFFFAOYSA-N 1-(6-chloroquinolin-2-yl)-1,1-difluoro-2-(4-fluorophenyl)-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=CC=1C(C(F)(F)C=1N=C2C=CC(Cl)=CC2=CC=1)(O)CN1C=NN=N1 DISWUHUIHBBZPN-UHFFFAOYSA-N 0.000 claims 2
- NOFDPNWFRGLYTK-UHFFFAOYSA-N 1-(6-chloroquinolin-2-yl)-1,1-difluoro-2-(4-methoxyphenyl)-3-(tetrazol-1-yl)propan-2-ol Chemical compound C1=CC(OC)=CC=C1C(O)(C(F)(F)C=1N=C2C=CC(Cl)=CC2=CC=1)CN1N=NN=C1 NOFDPNWFRGLYTK-UHFFFAOYSA-N 0.000 claims 2
- QRKOVNZOQNNGJY-UHFFFAOYSA-N 1-(6-chloroquinolin-2-yl)-1,1-difluoro-2-[2-fluoro-4-(trifluoromethyl)phenyl]-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(C(F)(F)F)C=C(F)C=1C(C(F)(F)C=1N=C2C=CC(Cl)=CC2=CC=1)(O)CN1C=NN=N1 QRKOVNZOQNNGJY-UHFFFAOYSA-N 0.000 claims 2
- SRBBDMDDBINJKI-UHFFFAOYSA-N 1-(6-chloroquinolin-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=C2C=CC(Cl)=CC2=CC=1)(O)CN1C=NN=N1 SRBBDMDDBINJKI-UHFFFAOYSA-N 0.000 claims 2
- AQTFAULFKXBOEC-UHFFFAOYSA-N 1-(6-chloroquinolin-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-2-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=C2C=CC(Cl)=CC2=CC=1)(O)CN1N=CN=N1 AQTFAULFKXBOEC-UHFFFAOYSA-N 0.000 claims 2
- VTBQSKCJQUNDHA-UHFFFAOYSA-N 1-(6-chloroquinolin-2-yl)-2-(2,5-difluorophenyl)-1,1-difluoro-3-(tetrazol-2-yl)propan-2-ol Chemical compound C=1C(F)=CC=C(F)C=1C(C(F)(F)C=1N=C2C=CC(Cl)=CC2=CC=1)(O)CN1N=CN=N1 VTBQSKCJQUNDHA-UHFFFAOYSA-N 0.000 claims 2
- HXYJDTISKMLHMZ-UHFFFAOYSA-N 1-(6-chloroquinolin-2-yl)-2-(3,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C(F)=CC=1C(C(F)(F)C=1N=C2C=CC(Cl)=CC2=CC=1)(O)CN1C=NN=N1 HXYJDTISKMLHMZ-UHFFFAOYSA-N 0.000 claims 2
- UKPFJMNQOUIOFT-UHFFFAOYSA-N 1-(6-chloroquinolin-2-yl)-2-[2-chloro-4-(trifluoromethyl)phenyl]-1,1-difluoro-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(C(F)(F)F)C=C(Cl)C=1C(C(F)(F)C=1N=C2C=CC(Cl)=CC2=CC=1)(O)CN1C=NN=N1 UKPFJMNQOUIOFT-UHFFFAOYSA-N 0.000 claims 2
- CJJPANKYCQOBAK-UHFFFAOYSA-N 1-(7-chloroisoquinolin-3-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=CC2=CC(Cl)=CC=C2C=1)(O)CN1C=NN=N1 CJJPANKYCQOBAK-UHFFFAOYSA-N 0.000 claims 2
- RYUBZLWHLBOAIJ-UHFFFAOYSA-N 1-[5-(4-bromophenyl)pyrazin-2-yl]-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=CC(=NC=1)C=1C=CC(Br)=CC=1)(O)CN1C=NN=N1 RYUBZLWHLBOAIJ-UHFFFAOYSA-N 0.000 claims 2
- SFANIAZLOAGMGY-UHFFFAOYSA-N 1-[5-(4-chlorophenyl)pyrazin-2-yl]-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=CC(=NC=1)C=1C=CC(Cl)=CC=1)(O)CN1C=NN=N1 SFANIAZLOAGMGY-UHFFFAOYSA-N 0.000 claims 2
- FUXCBKALBDKNQA-UHFFFAOYSA-N 1-[5-[4-(difluoromethoxy)phenyl]pyrazin-2-yl]-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=CC(=NC=1)C=1C=CC(OC(F)F)=CC=1)(O)CN1C=NN=N1 FUXCBKALBDKNQA-UHFFFAOYSA-N 0.000 claims 2
- WDNZYDPCYQMVFY-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-1-(6-fluoroquinolin-2-yl)-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=C2C=CC(F)=CC2=CC=1)(O)CN1C=NN=N1 WDNZYDPCYQMVFY-UHFFFAOYSA-N 0.000 claims 2
- UZRGYSSSYMJPJN-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-1-(6-fluoroquinoxalin-2-yl)-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=C2C=CC(F)=CC2=NC=1)(O)CN1C=NN=N1 UZRGYSSSYMJPJN-UHFFFAOYSA-N 0.000 claims 2
- DJMRCOHIQJQRNB-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-1-(6-methylquinolin-2-yl)-3-(tetrazol-1-yl)propan-2-ol Chemical compound C1=CC2=CC(C)=CC=C2N=C1C(F)(F)C(O)(C=1C(=CC(F)=CC=1)F)CN1C=NN=N1 DJMRCOHIQJQRNB-UHFFFAOYSA-N 0.000 claims 2
- OGJSRSSAVVZZNA-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-1-[4-(4-fluorophenyl)phenyl]-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1C=CC(=CC=1)C=1C=CC(F)=CC=1)(O)CN1C=NN=N1 OGJSRSSAVVZZNA-UHFFFAOYSA-N 0.000 claims 2
- ZVYYVKPDPSRBKS-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-1-[5-(4-fluorophenyl)pyrazin-2-yl]-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=CC(=NC=1)C=1C=CC(F)=CC=1)(O)CN1C=NN=N1 ZVYYVKPDPSRBKS-UHFFFAOYSA-N 0.000 claims 2
- SPXYZHSJGNFPNQ-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-1-[5-(4-fluorophenyl)pyrazin-2-yl]-3-(tetrazol-2-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=CC(=NC=1)C=1C=CC(F)=CC=1)(O)CN1N=CN=N1 SPXYZHSJGNFPNQ-UHFFFAOYSA-N 0.000 claims 2
- JLHUZXNJGGGINI-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-1-[5-(4-methoxyphenyl)pyrazin-2-yl]-3-(tetrazol-1-yl)propan-2-ol Chemical compound C1=CC(OC)=CC=C1C1=CN=C(C(F)(F)C(O)(CN2N=NN=C2)C=2C(=CC(F)=CC=2)F)C=N1 JLHUZXNJGGGINI-UHFFFAOYSA-N 0.000 claims 2
- MNNPKXJRKFWZAA-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-1-[5-[2-(4-fluorophenyl)ethyl]pyrazin-2-yl]-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=CC(CCC=2C=CC(F)=CC=2)=NC=1)(O)CN1C=NN=N1 MNNPKXJRKFWZAA-UHFFFAOYSA-N 0.000 claims 2
- DUSGQISEKVGKFY-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-1-[5-[2-(4-fluorophenyl)ethyl]pyrazin-2-yl]-3-(tetrazol-2-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=CC(CCC=2C=CC(F)=CC=2)=NC=1)(O)CN1N=CN=N1 DUSGQISEKVGKFY-UHFFFAOYSA-N 0.000 claims 2
- AKIJOMXPTBDWHL-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-1-[5-[2-(4-fluorophenyl)ethynyl]pyrazin-2-yl]-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=CC(=NC=1)C#CC=1C=CC(F)=CC=1)(O)CN1C=NN=N1 AKIJOMXPTBDWHL-UHFFFAOYSA-N 0.000 claims 2
- LEKFFQGYDLBDCX-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-1-[5-[2-(4-fluorophenyl)ethynyl]pyrazin-2-yl]-3-(tetrazol-2-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=CC(=NC=1)C#CC=1C=CC(F)=CC=1)(O)CN1N=CN=N1 LEKFFQGYDLBDCX-UHFFFAOYSA-N 0.000 claims 2
- JMBMKGWQEWYALI-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-1-[6-(4-fluorophenyl)pyridazin-3-yl]-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=NC(=CC=1)C=1C=CC(F)=CC=1)(O)CN1C=NN=N1 JMBMKGWQEWYALI-UHFFFAOYSA-N 0.000 claims 2
- FOZAIQXJYUGLJS-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)-1-(1,3-thiazol-2-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1SC=CN=1)(O)CN1C=NN=N1 FOZAIQXJYUGLJS-UHFFFAOYSA-N 0.000 claims 2
- DCYAGIBHSJIZOZ-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)-1-[4-[4-(2,2,2-trifluoroethoxy)phenyl]phenyl]propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1C=CC(=CC=1)C=1C=CC(OCC(F)(F)F)=CC=1)(O)CN1C=NN=N1 DCYAGIBHSJIZOZ-UHFFFAOYSA-N 0.000 claims 2
- KHUCXZVXCIZCPK-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)-1-[5-(2,2,2-trifluoroethoxy)quinolin-2-yl]propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=C2C=CC=C(OCC(F)(F)F)C2=CC=1)(O)CN1C=NN=N1 KHUCXZVXCIZCPK-UHFFFAOYSA-N 0.000 claims 2
- KPHGCXHRYBLGEY-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)-1-[5-[4-(2,2,2-trifluoroethoxy)phenyl]pyrazin-2-yl]propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=CC(=NC=1)C=1C=CC(OCC(F)(F)F)=CC=1)(O)CN1C=NN=N1 KPHGCXHRYBLGEY-UHFFFAOYSA-N 0.000 claims 2
- QXQQSHZOKPZQPB-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)-1-[5-[4-(trifluoromethoxy)phenyl]pyrazin-2-yl]propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=CC(=NC=1)C=1C=CC(OC(F)(F)F)=CC=1)(O)CN1C=NN=N1 QXQQSHZOKPZQPB-UHFFFAOYSA-N 0.000 claims 2
- RZKAKOGIOZMLDH-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)-1-[6-(trifluoromethoxy)quinolin-2-yl]propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=C2C=CC(OC(F)(F)F)=CC2=CC=1)(O)CN1C=NN=N1 RZKAKOGIOZMLDH-UHFFFAOYSA-N 0.000 claims 2
- KPKGPSNFLDYPEU-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)-1-[6-(trifluoromethoxy)quinoxalin-2-yl]propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=C2C=CC(OC(F)(F)F)=CC2=NC=1)(O)CN1C=NN=N1 KPKGPSNFLDYPEU-UHFFFAOYSA-N 0.000 claims 2
- XYEOIBVPDQXEJV-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)-1-[6-(trifluoromethyl)quinolin-2-yl]propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=C2C=CC(=CC2=CC=1)C(F)(F)F)(O)CN1C=NN=N1 XYEOIBVPDQXEJV-UHFFFAOYSA-N 0.000 claims 2
- MOPAFZKUSOPXKZ-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)-1-[6-[4-(trifluoromethoxy)phenyl]pyridazin-3-yl]propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=NC(=CC=1)C=1C=CC(OC(F)(F)F)=CC=1)(O)CN1C=NN=N1 MOPAFZKUSOPXKZ-UHFFFAOYSA-N 0.000 claims 2
- SRXPHHJSQDIVTF-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)-1-[6-[4-(trifluoromethyl)phenyl]pyridazin-3-yl]propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=NC(=CC=1)C=1C=CC(=CC=1)C(F)(F)F)(O)CN1C=NN=N1 SRXPHHJSQDIVTF-UHFFFAOYSA-N 0.000 claims 2
- DZQAFJYKZBZACL-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)-1-thiophen-2-ylpropan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1SC=CC=1)(O)CN1C=NN=N1 DZQAFJYKZBZACL-UHFFFAOYSA-N 0.000 claims 2
- PJVZYZOSBRLJGK-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1-(6-ethenylquinoxalin-2-yl)-1,1-difluoro-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=C2C=CC(C=C)=CC2=NC=1)(O)CN1C=NN=N1 PJVZYZOSBRLJGK-UHFFFAOYSA-N 0.000 claims 2
- UYMOJAADUWVIQI-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1-[5-(3,4-difluorophenyl)pyrazin-2-yl]-1,1-difluoro-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=CC(=NC=1)C=1C=C(F)C(F)=CC=1)(O)CN1C=NN=N1 UYMOJAADUWVIQI-UHFFFAOYSA-N 0.000 claims 2
- IDCSBJJQLLABCV-UHFFFAOYSA-N 2-(4-chloro-2-fluorophenyl)-1-(6-chloroquinoxalin-2-yl)-1,1-difluoro-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(Cl)C=C(F)C=1C(C(F)(F)C=1N=C2C=CC(Cl)=CC2=NC=1)(O)CN1C=NN=N1 IDCSBJJQLLABCV-UHFFFAOYSA-N 0.000 claims 2
- MLNSCZQVSKMUSO-UHFFFAOYSA-N 2-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(tetrazol-1-yl)propyl]quinoline-6-carbonitrile Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=C2C=CC(=CC2=CC=1)C#N)(O)CN1C=NN=N1 MLNSCZQVSKMUSO-UHFFFAOYSA-N 0.000 claims 2
- 108010078554 Aromatase Proteins 0.000 claims 2
- 102000014654 Aromatase Human genes 0.000 claims 2
- 108010009911 Cytochrome P-450 CYP11B2 Proteins 0.000 claims 2
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 claims 2
- 102000003849 Cytochrome P450 Human genes 0.000 claims 2
- 102100024329 Cytochrome P450 11B2, mitochondrial Human genes 0.000 claims 2
- 208000018522 Gastrointestinal disease Diseases 0.000 claims 2
- 108010074633 Mixed Function Oxygenases Proteins 0.000 claims 2
- 102000008109 Mixed Function Oxygenases Human genes 0.000 claims 2
- 108010015330 Steroid 17-alpha-Hydroxylase Proteins 0.000 claims 2
- 102000001854 Steroid 17-alpha-Hydroxylase Human genes 0.000 claims 2
- 208000012931 Urologic disease Diseases 0.000 claims 2
- 239000002246 antineoplastic agent Substances 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 229940127089 cytotoxic agent Drugs 0.000 claims 2
- 208000016097 disease of metabolism Diseases 0.000 claims 2
- 208000030159 metabolic disease Diseases 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 208000014001 urinary system disease Diseases 0.000 claims 2
- 102100027518 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial Human genes 0.000 claims 1
- PRPKWVAYXRKYPZ-UHFFFAOYSA-N 1-(4-bromo-1,3-thiazol-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1SC=C(Br)N=1)(O)CN1C=NN=N1 PRPKWVAYXRKYPZ-UHFFFAOYSA-N 0.000 claims 1
- IJWUZGPWBQCMCV-UHFFFAOYSA-N 1-(5,6-dichloroquinolin-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=C2C=CC(Cl)=C(Cl)C2=CC=1)(O)CN1C=NN=N1 IJWUZGPWBQCMCV-UHFFFAOYSA-N 0.000 claims 1
- MSWUQKNAWRQPCE-UHFFFAOYSA-N 1-(5-chlorothiophen-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1SC(Cl)=CC=1)(O)CN1C=NN=N1 MSWUQKNAWRQPCE-UHFFFAOYSA-N 0.000 claims 1
- SNJWBEVAANRMGD-UHFFFAOYSA-N 1-(6-bromo-1,3-benzothiazol-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1SC2=CC(Br)=CC=C2N=1)(O)CN1C=NN=N1 SNJWBEVAANRMGD-UHFFFAOYSA-N 0.000 claims 1
- VWIDQLCQMLJPJT-UHFFFAOYSA-N 1-(6-chloro-1,3-benzothiazol-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1SC2=CC(Cl)=CC=C2N=1)(O)CN1C=NN=N1 VWIDQLCQMLJPJT-UHFFFAOYSA-N 0.000 claims 1
- XJBIYNPVUFIELG-UHFFFAOYSA-N 1-(6-chloroquinoxalin-2-yl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=C2C=CC(Cl)=CC2=NC=1)(O)CN1C=NN=N1 XJBIYNPVUFIELG-UHFFFAOYSA-N 0.000 claims 1
- OWJJEBKOZTVUJO-UHFFFAOYSA-N 1-[6-(difluoromethyl)quinolin-2-yl]-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=C2C=CC(=CC2=CC=1)C(F)F)(O)CN1C=NN=N1 OWJJEBKOZTVUJO-UHFFFAOYSA-N 0.000 claims 1
- UZYJYHPEBHBKRD-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-1-pyrimidin-2-yl-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=CC=CN=1)(O)CN1C=NN=N1 UZYJYHPEBHBKRD-UHFFFAOYSA-N 0.000 claims 1
- MJGVYPBMZYOAES-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)-1-[6-(2,2,2-trifluoroethoxy)quinolin-2-yl]propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=C2C=CC(OCC(F)(F)F)=CC2=CC=1)(O)CN1C=NN=N1 MJGVYPBMZYOAES-UHFFFAOYSA-N 0.000 claims 1
- KBZDWTOFUXRRCG-UHFFFAOYSA-N 2-(4-chloro-2-fluorophenyl)-1-(6-chloroquinolin-2-yl)-1,1-difluoro-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(Cl)C=C(F)C=1C(C(F)(F)C=1N=C2C=CC(Cl)=CC2=CC=1)(O)CN1C=NN=N1 KBZDWTOFUXRRCG-UHFFFAOYSA-N 0.000 claims 1
- XGYBLBUZOUTMGQ-UHFFFAOYSA-N 4-[2-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(tetrazol-1-yl)propyl]-1,3-thiazol-4-yl]benzonitrile Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1SC=C(N=1)C=1C=CC(=CC=1)C#N)(O)CN1C=NN=N1 XGYBLBUZOUTMGQ-UHFFFAOYSA-N 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 208000035473 Communicable disease Diseases 0.000 claims 1
- 108010052832 Cytochromes Proteins 0.000 claims 1
- 102000018832 Cytochromes Human genes 0.000 claims 1
- 208000017701 Endocrine disease Diseases 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 206010017533 Fungal infection Diseases 0.000 claims 1
- 101000861278 Homo sapiens 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial Proteins 0.000 claims 1
- 101000615488 Homo sapiens Methyl-CpG-binding domain protein 2 Proteins 0.000 claims 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 1
- 102100021695 Lanosterol 14-alpha demethylase Human genes 0.000 claims 1
- 101710146773 Lanosterol 14-alpha demethylase Proteins 0.000 claims 1
- 102100021299 Methyl-CpG-binding domain protein 2 Human genes 0.000 claims 1
- 208000031888 Mycoses Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000010195 Onychomycosis Diseases 0.000 claims 1
- 229930182558 Sterol Natural products 0.000 claims 1
- 229930003316 Vitamin D Natural products 0.000 claims 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims 1
- 239000004037 angiogenesis inhibitor Substances 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 229940121375 antifungal agent Drugs 0.000 claims 1
- 239000003429 antifungal agent Substances 0.000 claims 1
- 235000010290 biphenyl Nutrition 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 239000002254 cytotoxic agent Substances 0.000 claims 1
- 208000010643 digestive system disease Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000002526 effect on cardiovascular system Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 208000030172 endocrine system disease Diseases 0.000 claims 1
- 208000018685 gastrointestinal system disease Diseases 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 125000001288 lysyl group Chemical group 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 230000002062 proliferating effect Effects 0.000 claims 1
- 229930002330 retinoic acid Natural products 0.000 claims 1
- 108010068815 steroid hormone 7-alpha-hydroxylase Proteins 0.000 claims 1
- 150000003432 sterols Chemical class 0.000 claims 1
- 235000003702 sterols Nutrition 0.000 claims 1
- 230000009885 systemic effect Effects 0.000 claims 1
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 claims 1
- 201000005882 tinea unguium Diseases 0.000 claims 1
- 229960001727 tretinoin Drugs 0.000 claims 1
- 235000019166 vitamin D Nutrition 0.000 claims 1
- 239000011710 vitamin D Substances 0.000 claims 1
- 150000003710 vitamin D derivatives Chemical class 0.000 claims 1
- 229940046008 vitamin d Drugs 0.000 claims 1
- 244000052769 pathogen Species 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161500372P | 2011-06-23 | 2011-06-23 | |
| US61/500,372 | 2011-06-23 | ||
| US201261611917P | 2012-03-16 | 2012-03-16 | |
| US61/611,917 | 2012-03-16 | ||
| PCT/US2012/043292 WO2012177725A1 (en) | 2011-06-23 | 2012-06-20 | Metalloenzyme inhibitor compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016234551A Division JP6419136B2 (ja) | 2011-06-23 | 2016-12-01 | 金属酵素化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014517069A JP2014517069A (ja) | 2014-07-17 |
| JP2014517069A5 true JP2014517069A5 (enExample) | 2016-08-12 |
| JP6223329B2 JP6223329B2 (ja) | 2017-11-01 |
Family
ID=47362422
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014517112A Expired - Fee Related JP6223329B2 (ja) | 2011-06-23 | 2012-06-20 | 金属酵素化合物 |
| JP2014517113A Pending JP2014523880A (ja) | 2011-06-23 | 2012-06-20 | 金属酵素化合物 |
| JP2016234551A Expired - Fee Related JP6419136B2 (ja) | 2011-06-23 | 2016-12-01 | 金属酵素化合物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014517113A Pending JP2014523880A (ja) | 2011-06-23 | 2012-06-20 | 金属酵素化合物 |
| JP2016234551A Expired - Fee Related JP6419136B2 (ja) | 2011-06-23 | 2016-12-01 | 金属酵素化合物 |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US8940735B2 (enExample) |
| EP (2) | EP2723730A4 (enExample) |
| JP (3) | JP6223329B2 (enExample) |
| KR (2) | KR101964195B1 (enExample) |
| CN (3) | CN109400594A (enExample) |
| AR (1) | AR094127A1 (enExample) |
| AU (2) | AU2012273004B2 (enExample) |
| BR (1) | BR102012015457A2 (enExample) |
| CA (2) | CA2838916C (enExample) |
| CL (1) | CL2013003679A1 (enExample) |
| CO (1) | CO6930358A2 (enExample) |
| EA (2) | EA201490052A1 (enExample) |
| EC (1) | ECSP14013159A (enExample) |
| IN (1) | IN2014DN00286A (enExample) |
| MX (1) | MX2013015159A (enExample) |
| PH (1) | PH12013502622A1 (enExample) |
| UY (1) | UY34156A (enExample) |
| WO (2) | WO2012177728A1 (enExample) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5511680B2 (ja) | 2007-12-19 | 2014-06-04 | キャンサー・リサーチ・テクノロジー・リミテッド | ピリド［２，３−ｂ］ピラジン−８−置換化合物及びその使用 |
| NZ601085A (en) | 2010-02-01 | 2015-04-24 | Cancer Rec Tech Ltd | 1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy |
| JP6159318B2 (ja) * | 2011-06-19 | 2017-07-05 | ヴィアメット ファーマスーティカルズ，インコーポレイテッド | 金属酵素阻害化合物 |
| WO2012177728A1 (en) * | 2011-06-23 | 2012-12-27 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
| SI2788343T1 (sl) | 2011-12-11 | 2019-09-30 | Viamet Pharmaceuticals (NC), Inc. | Spojine inhibitorja metaloencimov |
| EA026209B1 (ru) | 2012-01-20 | 2017-03-31 | Ваймет Фармасьютикалс, Инк. | Соединения, ингибирующие металлоферменты |
| US9414596B2 (en) * | 2012-01-20 | 2016-08-16 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
| WO2013135674A1 (en) * | 2012-03-12 | 2013-09-19 | Syngenta Participations Ag | Insecticidal 2-aryl-acetamide compounds |
| US9655363B2 (en) * | 2013-02-04 | 2017-05-23 | Syngenta Participations Ag | Microbiocides |
| EP2984081B1 (en) * | 2013-04-12 | 2017-08-09 | Bayer CropScience Aktiengesellschaft | Novel triazole derivatives |
| CA2909217A1 (en) | 2013-04-12 | 2014-10-16 | Bayer Cropscience Aktiengesellschaft | Novel triazole derivatives |
| US9550752B2 (en) | 2013-04-12 | 2017-01-24 | Bayer Cropscience Aktiengesellschaft | Triazolinthione derivatives |
| US9447073B2 (en) | 2013-05-28 | 2016-09-20 | Viamet Pharmaceuticals, Inc. | Fungicidal compositions |
| KR20160018811A (ko) * | 2013-06-12 | 2016-02-17 | 비아멧 파마슈티컬즈, 인코포레이티드 | 금속 효소 억제 화합물 |
| GB201320729D0 (en) | 2013-11-25 | 2014-01-08 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
| GB201320732D0 (en) | 2013-11-25 | 2014-01-08 | Cancer Rec Tech Ltd | Methods of chemical synthesis |
| AR099120A1 (es) | 2014-01-20 | 2016-06-29 | Bayer Cropscience Ag | Derivados de quinolina como insecticidas y acaricidas |
| AU2015231275B2 (en) | 2014-03-19 | 2019-03-07 | Mycovia Pharmaceuticals, Inc. | Antifungal compound process |
| US10399943B2 (en) | 2014-03-19 | 2019-09-03 | Mycovia Pharmaceuticals, Inc. | Antifungal compound process |
| WO2015143192A1 (en) | 2014-03-19 | 2015-09-24 | Viamet Pharmaceuticals, Inc. | 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-substituted-pyridin-2-yl)-3-(1h-tetrazol-1-yl)propan-2-ols and processes for their preparation |
| BR112016021257B1 (pt) | 2014-03-19 | 2021-03-02 | Viamet Pharmaceuticals (NC), Inc. | 2-(2,4- difluorofenil-1,1-diflúor-1-(5-substituído-piridin-2-il)-3- (1h-tetrazol-1-il)propan-2-óis e processos para preparação e uso dos mesmos |
| EP3119749A4 (en) * | 2014-03-19 | 2017-12-13 | Viamet Pharmaceuticals, Inc. | Antifungal compound process |
| JP6572234B2 (ja) | 2014-03-19 | 2019-09-04 | ヴィアメット ファーマスーティカルズ（エヌシー），インコーポレイテッド | 抗真菌化合物の調製方法 |
| EP3119771B1 (en) | 2014-03-19 | 2020-05-06 | Mycovia Pharmaceuticals, Inc. | Antifungal compound process |
| MX365494B (es) * | 2014-03-19 | 2019-06-05 | Us Health | Procedimiento de compuesto antifungico. |
| JP2017514790A (ja) * | 2014-03-19 | 2017-06-08 | ヴィアメット ファーマスーティカルズ，インコーポレイテッド | 抗真菌化合物の調製方法 |
| JP2017509646A (ja) | 2014-03-19 | 2017-04-06 | ヴィアメット ファーマスーティカルズ，インコーポレイテッド | 抗真菌化合物の調製方法 |
| US9663491B2 (en) * | 2014-04-15 | 2017-05-30 | Dow Agrosciences Llc | Metalloenzyme inhibitor compounds as fungicides |
| JP6623015B2 (ja) * | 2014-09-29 | 2019-12-18 | 国立研究開発法人理化学研究所 | 植物の耐塩性向上剤 |
| JP2017531636A (ja) | 2014-10-02 | 2017-10-26 | バイエル・クロップサイエンス・アクチェンゲゼルシャフト | 殺菌剤として有用な新規トリアゾール誘導体 |
| CN104844652A (zh) * | 2015-02-10 | 2015-08-19 | 扬子江药业集团南京海陵药业有限公司 | 艾沙康唑磷酸酯及其制备方法和用途 |
| EP3277674B1 (en) | 2015-04-02 | 2019-09-11 | Bayer CropScience Aktiengesellschaft | Triazol derivatives as fungicides |
| DK3297998T3 (da) | 2015-05-18 | 2020-03-16 | Viamet Pharmaceuticals Nc Inc | Antisvampeforbindelser |
| US10513505B2 (en) | 2015-09-18 | 2019-12-24 | Nqp 1598, Ltd. | Antifungal compound process |
| EP3376866A4 (en) | 2015-11-17 | 2019-04-10 | Dow Agrosciences LLC | 4 - ((6- (2- (2,4-DIFLUORPHENYL) -1,1-DIFLUOR-2-OXOETHYL) PYRIDIN-3-YL) BENZONITRIL AND METHOD OF PREPARING THEREOF |
| EP3377475A4 (en) | 2015-11-17 | 2019-04-10 | Dow Agrosciences Llc | 4 - ((6-2- (2,4-difluorophenyl) -1,1-difluoro-2-hydroxy-3- (1H-1,2,4-triazol-1-YL) PROPYL) PYRIDINE-3-YL ) OXY) BENZONITRIL AND METHOD OF PREPARING THEREOF |
| CN105801571A (zh) * | 2016-04-14 | 2016-07-27 | 上海大学 | 杂环二氟甲基化的环氧乙烷化合物及其制备方法 |
| ES2970715T3 (es) | 2016-12-22 | 2024-05-30 | Prec Pharmaceuticals Inc | Composiciones y métodos para inhibir la actividad de la arginasa |
| CN106905273B (zh) * | 2017-01-18 | 2019-05-14 | 中山大学 | 4-氧杂-4,5,6,7-四氢苯并[b]呋喃-3-羧酸类化合物及其应用 |
| JP7129420B6 (ja) | 2017-03-30 | 2024-02-02 | エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト | Ｈｐｋ１阻害剤としてのイソキノリン |
| WO2019092086A1 (en) | 2017-11-13 | 2019-05-16 | Bayer Aktiengesellschaft | Tetrazolylpropyl derivatives and their use as fungicides |
| WO2020023560A1 (en) | 2018-07-24 | 2020-01-30 | F. Hoffmann-La Roche Ag | Isoquinoline compounds and uses thereof |
| TW202024053A (zh) | 2018-10-02 | 2020-07-01 | 美商建南德克公司 | 異喹啉化合物及其用途 |
| US11612606B2 (en) | 2018-10-03 | 2023-03-28 | Genentech, Inc. | 8-aminoisoquinoline compounds and uses thereof |
| CN110672753B (zh) * | 2019-11-04 | 2022-05-20 | 青海省农林科学院 | 一种氟咯草酮异构体的拆分和检测方法 |
| GB201916600D0 (en) * | 2019-11-14 | 2020-01-01 | Syngenta Crop Protection Ag | 81991-gb-reg-org-nat-1 |
| GB202001564D0 (en) * | 2020-02-05 | 2020-03-18 | Kings College | Compounds |
| CN114686450B (zh) * | 2020-12-28 | 2024-04-16 | 苏州引航生物科技有限公司 | 经修饰的维生素d羟化酶突变体及其应用 |
| CN117069693A (zh) * | 2022-05-16 | 2023-11-17 | 上海济煜医药科技有限公司 | 一类含胺基结构化合物的制备方法及作为抗菌剂的应用 |
| CN115322151A (zh) * | 2022-08-23 | 2022-11-11 | 河南师范大学 | 铜催化合成手性多立体中心吡唑烷类化合物的方法 |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8301699D0 (en) * | 1983-01-21 | 1983-02-23 | Pfizer Ltd | Antifungal agents |
| DE3461637D1 (en) | 1983-02-16 | 1987-01-22 | Pfizer Ltd | Triazole antifungal agents |
| GB8304282D0 (en) * | 1983-02-16 | 1983-03-23 | Pfizer Ltd | Antifungal agents |
| GB8305377D0 (en) * | 1983-02-25 | 1983-03-30 | Pfizer Ltd | Antifungal agents |
| DE3313073A1 (de) * | 1983-04-12 | 1984-10-18 | Bayer Ag, 5090 Leverkusen | 1-azolyl-3-pyrazolyl-2-propanol-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide |
| US5087240A (en) | 1983-08-18 | 1992-02-11 | Drug Delivery Systems Inc. | Transdermal drug patch with conductive fibers |
| US4921475A (en) | 1983-08-18 | 1990-05-01 | Drug Delivery Systems Inc. | Transdermal drug patch with microtubes |
| US4483863A (en) * | 1984-01-20 | 1984-11-20 | Pfizer Inc. | Triazole antifungal agents |
| US4616206A (en) * | 1984-09-07 | 1986-10-07 | Eaton Corporation | Circuit breaker and shunt trip apparatus combined within single pole device |
| GB8506619D0 (en) * | 1985-03-14 | 1985-04-17 | Pfizer Ltd | Triazole antifungal agents |
| US4738851A (en) | 1985-09-27 | 1988-04-19 | University Of Iowa Research Foundation, Inc. | Controlled release ophthalmic gel formulation |
| US5163899A (en) | 1987-03-20 | 1992-11-17 | Drug Delivery Systems Inc. | Transdermal drug delivery system |
| US5312325A (en) | 1987-05-28 | 1994-05-17 | Drug Delivery Systems Inc | Pulsating transdermal drug delivery system |
| GB8804164D0 (en) | 1988-02-23 | 1988-03-23 | Tucker J M | Bandage for administering physiologically active compound |
| US4882150A (en) | 1988-06-03 | 1989-11-21 | Kaufman Herbert E | Drug delivery system |
| GB8819308D0 (en) | 1988-08-13 | 1988-09-14 | Pfizer Ltd | Triazole antifungal agents |
| US5008110A (en) | 1988-11-10 | 1991-04-16 | The Procter & Gamble Company | Storage-stable transdermal patch |
| US5088977A (en) | 1988-12-21 | 1992-02-18 | Drug Delivery Systems Inc. | Electrical transdermal drug applicator with counteractor and method of drug delivery |
| US5521222A (en) | 1989-09-28 | 1996-05-28 | Alcon Laboratories, Inc. | Topical ophthalmic pharmaceutical vehicles |
| DE69009946T2 (de) | 1989-12-04 | 1994-11-03 | Searle & Co | System zur transdermalen Albuterol Applikation. |
| US5077033A (en) | 1990-08-07 | 1991-12-31 | Mediventures Inc. | Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide |
| JP2594486B2 (ja) | 1991-01-15 | 1997-03-26 | アルコン ラボラトリーズ インコーポレイテッド | 局所的眼薬組成物 |
| GB9107055D0 (en) * | 1991-04-04 | 1991-05-22 | Pfizer Ltd | Triazole antifungal agents |
| US5352456A (en) | 1991-10-10 | 1994-10-04 | Cygnus Therapeutic Systems | Device for administering drug transdermally which provides an initial pulse of drug |
| TW212798B (enExample) * | 1991-11-25 | 1993-09-11 | Takeda Pharm Industry Co Ltd | |
| JP3415865B2 (ja) * | 1991-11-25 | 2003-06-09 | 武田薬品工業株式会社 | 光学活性アゾール化合物およびその用途 |
| JPH07502219A (ja) | 1991-12-18 | 1995-03-09 | ミネソタ マイニング アンド マニュファクチャリング カンパニー | 多重層型バリアー構造体 |
| ATE132381T1 (de) | 1992-01-29 | 1996-01-15 | Voelkl Franz Ski | Ballspielschläger, insbesondere tennisschläger |
| GB9317491D0 (en) * | 1993-08-23 | 1993-10-06 | Fujisawa Pharmaceutical Co | New compound and a process for preparation thereof |
| JP3452213B2 (ja) * | 1994-07-05 | 2003-09-29 | エーザイ株式会社 | 抗真菌剤及びその製造方法 |
| IL114193A (en) | 1994-06-20 | 2000-02-29 | Teva Pharma | Ophthalmic pharmaceutical compositions based on sodium alginate |
| ES2094688B1 (es) | 1994-08-08 | 1997-08-01 | Cusi Lab | Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion. |
| GB9512961D0 (en) | 1995-06-26 | 1995-08-30 | Pfizer Ltd | Antifungal agents |
| IT1283911B1 (it) | 1996-02-05 | 1998-05-07 | Farmigea Spa | Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo |
| US5800807A (en) | 1997-01-29 | 1998-09-01 | Bausch & Lomb Incorporated | Ophthalmic compositions including glycerin and propylene glycol |
| US6261547B1 (en) | 1998-04-07 | 2001-07-17 | Alcon Manufacturing, Ltd. | Gelling ophthalmic compositions containing xanthan gum |
| US6197934B1 (en) | 1998-05-22 | 2001-03-06 | Collagenesis, Inc. | Compound delivery using rapidly dissolving collagen film |
| JP2000344744A (ja) * | 1999-06-04 | 2000-12-12 | Ss Pharmaceut Co Ltd | アセトフェノン誘導体およびその製法 |
| WO2004018485A1 (en) * | 2002-08-26 | 2004-03-04 | Ranbaxy Laboratories Limited | Azole derivatives as antifungal agents |
| US8680270B2 (en) * | 2006-11-21 | 2014-03-25 | Viamet Pharmaceuticals, Inc. | Metallo-oxidoreductase inhibitors using metal binding moieties in combination with targeting moieties |
| AU2009303475B2 (en) * | 2008-10-15 | 2012-09-13 | Amgen Inc. | Spirocyclic GPR40 modulators |
| DK2563771T3 (en) * | 2010-04-24 | 2016-02-29 | Viamet Pharmaceuticals Inc | Metalloenzyminhibitorforbindelser |
| JP6159318B2 (ja) | 2011-06-19 | 2017-07-05 | ヴィアメット ファーマスーティカルズ，インコーポレイテッド | 金属酵素阻害化合物 |
| EP3067350B1 (en) * | 2011-06-19 | 2018-06-13 | Viamet Pharmaceuticals (NC), Inc. | Metalloenzyme inhibitor compounds |
| WO2012177728A1 (en) * | 2011-06-23 | 2012-12-27 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
| SI2788343T1 (sl) | 2011-12-11 | 2019-09-30 | Viamet Pharmaceuticals (NC), Inc. | Spojine inhibitorja metaloencimov |
| JP6189289B2 (ja) * | 2011-12-30 | 2017-08-30 | テトラ ラバル ホールディングス アンド ファイナンス エス エイ | 改善された近赤外吸収体 |
| US9414596B2 (en) | 2012-01-20 | 2016-08-16 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
-
2012
- 2012-06-20 WO PCT/US2012/043295 patent/WO2012177728A1/en not_active Ceased
- 2012-06-20 EP EP12801805.8A patent/EP2723730A4/en not_active Withdrawn
- 2012-06-20 WO PCT/US2012/043292 patent/WO2012177725A1/en not_active Ceased
- 2012-06-20 AU AU2012273004A patent/AU2012273004B2/en not_active Ceased
- 2012-06-20 CA CA2838916A patent/CA2838916C/en not_active Expired - Fee Related
- 2012-06-20 EA EA201490052A patent/EA201490052A1/ru unknown
- 2012-06-20 US US13/528,283 patent/US8940735B2/en active Active
- 2012-06-20 IN IN286DEN2014 patent/IN2014DN00286A/en unknown
- 2012-06-20 KR KR1020147001615A patent/KR101964195B1/ko not_active Expired - Fee Related
- 2012-06-20 AU AU2012273007A patent/AU2012273007A1/en not_active Abandoned
- 2012-06-20 MX MX2013015159A patent/MX2013015159A/es unknown
- 2012-06-20 CN CN201811257707.5A patent/CN109400594A/zh active Pending
- 2012-06-20 JP JP2014517112A patent/JP6223329B2/ja not_active Expired - Fee Related
- 2012-06-20 EA EA201490088A patent/EA025266B1/ru not_active IP Right Cessation
- 2012-06-20 CA CA2839883A patent/CA2839883A1/en not_active Abandoned
- 2012-06-20 JP JP2014517113A patent/JP2014523880A/ja active Pending
- 2012-06-20 PH PH1/2013/502622A patent/PH12013502622A1/en unknown
- 2012-06-20 KR KR1020147001619A patent/KR20140039059A/ko not_active Withdrawn
- 2012-06-20 CN CN201280040552.4A patent/CN103930418A/zh active Pending
- 2012-06-20 US US13/528,319 patent/US8883797B2/en active Active
- 2012-06-20 EP EP12802142.5A patent/EP2723731B1/en not_active Not-in-force
- 2012-06-20 CN CN201280040551.XA patent/CN103857675A/zh active Pending
- 2012-06-22 AR ARP120102236A patent/AR094127A1/es not_active Application Discontinuation
- 2012-06-22 UY UY0001034156A patent/UY34156A/es not_active Application Discontinuation
- 2012-06-25 BR BRBR102012015457-9A patent/BR102012015457A2/pt not_active Application Discontinuation
-
2013
- 2013-12-20 CL CL2013003679A patent/CL2013003679A1/es unknown
-
2014
- 2014-01-17 CO CO14008727A patent/CO6930358A2/es not_active Application Discontinuation
- 2014-01-20 EC ECSP14013159 patent/ECSP14013159A/es unknown
-
2016
- 2016-12-01 JP JP2016234551A patent/JP6419136B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014517069A5 (enExample) | ||
| JP2014517068A5 (enExample) | ||
| JP2014523880A5 (enExample) | ||
| DK2788343T3 (en) | METALLOENZYMIN INHIBITOR COMPOUNDS | |
| AU2017232080B2 (en) | Metalloenzyme inhibitor compounds | |
| AU2011326487B2 (en) | Metalloenzyme inhibitor compounds | |
| CA2674436A1 (en) | Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors | |
| JP2018515555A5 (enExample) | ||
| CA2592986A1 (en) | Heteroaromatic quinoline compounds | |
| JP2007523208A5 (enExample) | ||
| NZ595553A (en) | VINYL INDAZOLYL COMPOUND; (E)-2-(4-(2-(5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazol-3-yl)vinyl)-1H-pyrazol-1-yl)ethanol | |
| RU2501791C2 (ru) | Производное триазола или его соль | |
| NZ604004A (en) | Pyridone and aza-pyridone compounds and methods of use | |
| HRP20160172T1 (hr) | Spojevi koji su inhibitori metaloenzima | |
| JP2010526130A5 (enExample) | ||
| JP2015504095A5 (enExample) | ||
| JP2016526535A5 (enExample) | ||
| JP2018519323A5 (enExample) | ||
| NZ592297A (en) | 2-Aryl-5-heteroaryl pyridine and pyrimidine derivatives as pharmaceutical active agents | |
| RU2018112237A (ru) | Новые бициклические соединения в качестве дуальных ингибиторов atx/ca | |
| CA2557115A1 (en) | Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors | |
| JP2015531774A5 (enExample) | ||
| JP2016164184A5 (enExample) | ||
| JP2014528450A5 (enExample) | ||
| JP2010525024A5 (enExample) |